Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 4, 2007, Pages 421-432

  Sinzig, Judith ^a   Döpfner, Manfred ^a   Lehmkuhl, G ^a   Uebel, H ^b   Schmeck, K ^c   Poustka, F ^c   Gerber, W D ^d   Gunter M ^e   Knolker U ^f   Gehrke, M ^g   Hassler F ^h   Resch, F ⁱ   Brunger M ^j   Ose, C ^k   Fischer, R ^l  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

^g Städtische Kliniken Frankfurt Main Höchst   (Germany)

^h UNIVERSITY OF ROSTOCK   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j NONE   (Germany)

^k UNIVERSITY OF DUISBURG ESSEN   (Germany)

^l MEDICE Arzneimittel Pütter GmbH Co KG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LONG ACTING DRUG; MEDIKINET RETARD; METHYLPHENIDATE; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUSTAINED DRUG RELEASE; SYMPTOM CHECKLIST 90; TREATMENT DURATION;

ADOLESCENT; AGGRESSION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; CONDUCT DISORDER; DELAYED-ACTION PREPARATIONS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FACULTY; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PARENTS; SCHOOLS;

EID: 34548714609     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0011     Document Type: Article

References (69)

1. Achenbach TM, McConaughy SH, Howell CT: Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psycholog Bull 101:213-232, 1987.
2. th edition, Text revision (DSM-IV-TR). Washington, DC, American Psychiatric Association, 2000.
3. Angold A, Costello EJ, Erkanli A: Comorbidity. J Child Psychol Psychiatry 40:57-87, 1999.
4. August GJ, Stewart MA, Holmes CS: A four-year follow-up of hyperactive boys with and without conduct disorder. Br J Psychiatry 143:192-198, 1983.
5. Barkley RA (ed.): Attention Deficit Hyperactivity Disorder: A Handbook For Diagnosis and Treatment. New York, Guildford Press, 1990.
6. Barkley RA (ed.): Attention Deficit Hyperactivity Disorder. A Clinical Workbook. New York, Guilford Press, 1991.
7. Barkley RA, McMurray MB, Edelbrock CS, Robbins K: The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry 28:873-881, 1989
8. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS: A double-blind placebo controlled study of desipramine in treatment of ADD: I Efficacy. J Am Child Adolesc Psychiatry 28:777-784, 1989.
9. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S: A double-blind placebo controlled study of desipramine in treatment of ADD: III Lack of impact of comorbidity and familiy history factors on clinical response. J Am Child Adolesc Psychiatry 32:199-204, 1993.
10. Brühl B, Döpfner M, Lehmkuhl G: Der Fremdbeurteilungsbogen für hyperkinetische Störungen (FBB-HKS) - Prävalenz hyperkinetischer Störungen im Elternurteil und psychometrische Kriterien. Kindheit und Entwicklung 9:116-126, 2000.
11. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld, H, Kuiper M: Pindolol and methylphenidate in children with attention-deficit/hyperactivity disorder. Clinical and side-effects. J Child Psychol Psychiatry 37:587-595, 1996.
12. Buitelaar JK, van der Gaag RJ, Cohen-Kettnis P, Melman CTM: A randomized controlled trial of riperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239-248, 2001.
13. Campbell M, Cohen IL, Small AM: Drugs in aggressive behavior. J Am Acad Child Adolesc Psychiatry 21:107-117, 1982.
14. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, Anderson L: Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656, 1984.
15. Campbell M, Adams PB, Small AM, Kafantaris V, Silva RR, Shell J, Perry R, Overall JE: Lithium in hospitalized aggressive children with conduct disorder: A double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 34:445-453, 1995.
16. Cantwell D: Hyperkinetic Syndrome. Child and Adolescent Psychiatry: Modern Approaches. Edited by Rutter M, Harsov L. Oxford, England, Blackwell Science, 1977.
17. Cohen J: Statistical power analysis for the behavioral sciences, 2nd edition. Hillsdale, (New Jersey), Erlbaum, 1988.
18. Collier CP: Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Clin Pharmacokinet 10:269-278, 1985.
19. Conners CK, Kramer R, Rothschild GH et al.: Treatment of young delinquent boys with diphenylhydantoin sodium and methylphenidate. Arch Gen Psychiatry 24:156-160, 1971.
20. Connor DF, Barkley RA, Davis HT: A pilot study of methylphendiate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr 15-25, 2000.
21. Connor DF, Stephani J, Glatt SJ, Ivan D, Lopez ID, Jackson D, Melloni Jr. RH: Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 41:253-261, 2002.
22. Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M: Carbamazepine in aggressive children with conduct disorder: A double-blind placebo controlled study. J Am Acad Child Adolesc Psychiatry 35:480-490, 1996.
23. Dollfuss S: Indication for clonidine in child psychiatry. L'encephale 19:83-87, 1993.
24. Donovan SJ, Stewart J, Nunes EV, Quitkin FM, Parides M, Daniel W, Susser E, Klein DF: Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. Am J Psychiatry 157:818-820, 2000.
25. Döpfner M, Lehmkuhl G: Diagnostik-System für Psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV (DISYPS-KJ), 2. korrigierte und ergänzte Auflage. Bern, Huber, 2000.
26. Döpfner M, Lehmkuhl G: Evidenzbasierte Therapie von Kindern und Jugendlichen mit Aufmerksamkeits defizit-/Hyperaktivitätsstörung (ADHS) [Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)]. Praxis der Kinderpsychologie und Kinderpsychiatrie 51:419-440, 2002.
27. Döpfner M, Banaschewski T, Schmidt J et al.: Long acting methylphenidate preparation (Medikinet®-Retard) in children with ADHD- effective and safe in a multicenter study. Nervenheilkunde 22:85-92, 2003.
28. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Günter M, Hässler F, Ose C, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl G: Comparative efficacy of once-a-day extended-release methylphenidate, two- times- daily Immediate-release methylphenidate, and placebo in a laboratory school setting. Eur J Child Adolesc Psychiatry 13 (Suppl 1):93-101, 2004.
29. Döpfner M, Breuer D, Schürmann S, Wolff Metternich T, Rademacher C, Lehmkuhl G: Effectiveness of an adaptive multimodal treatment in children with attention deficit hyperactivity disorder - global outcome. Eur Child Adolesc Psychiatry 13 (Suppl 1):I/117-I/129, 2004.
30. Eisenberg L, Lachman R, Molling PA et al.: A psychopharmacological experiment in a training school for delinquent boys: Methods, problems, findings. Am J Orthopsychiatry 33:431-447, 1963.
31. Farrington DP, Loeber R, Van Kammen WB: Long-term criminal outcomes of hyperactivity-impulsivity-attention deficit and conduct problems in childhood. In: Straight and Devious Pathways From Childhood To Adulthood. Edited by Robins LN, Rutter M. New York, Cambridge University Press, pp 62-81, 1990.
32. Findling RL, McNemara NK, Braniky LA, Schluchter MD, Lemon E, Blumer J: A double-bind pilot study of risperidone in the treatment of conduct disorder. J Am Child Adolesc Psychiatry 39:509-516, 2000.
33. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L: Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 29:710-718, 1990.
34. Gerardin P, Cohen D, Mazet P, Flament MF: Drug treatment of conduct disorder in young people. Euro Neuropsychopharmacol 12:361-370, 2002.
35. Greenhill LL, Solomon M, Pleak R, Ambrosini P: Molindone hydrochloride in the treatment of hospitalized children with conduct disorder. J Clin Psychiatry 46:20-25, 1985.
36. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T: Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. J Am Acad Child Adolesc Psychiatry 40:180-187, 2001.
37. Hechtmann L, Greenfiled B: Long-term use of stimulants in children with attention deficit hypeactivity disorder. Pediatric Drugs 5:787-794, 2003.
38. Hinshaw SP, Heller T, McHale JP: Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate. J Consult Clin Psychol 60:274-281, 1992.
39. Kaplan SL, Busner J, Kupietz S, Wassermann E, Segal B: Effects of methylphenidate on adolescents with aggressive conduct disorder and ADHD: A preliminary report. J Am Acad Child Adolesc Psychiatry 29:719-723, 1990.
40. Kemph JP, DeVane CL, Levin GM, Jareckej R, Miller RL: Treatment of aggressive children with clonidine: Results of an open pilot study. J Am Child Adoles Psychiatry 32:577-581, 1993.
41. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S: Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 54:1073-1080, 1997.
42. Kolko DJ, Bukstein OG, Barron J: Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings. J Am Acad Child Adolesc Psychiatry 38:578-586, 1990.
43. Kruesi MJP, Leilo DF: Disorders of conduct and behavior. In: Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders, 2nd edition. Edited by Wiener JM pp 402-447, 1996.
44. Loney J, Prinz RJ, Mishalow J, Joad J: Hyperkinetic/aggressive boys in treatment: Predictors of clinical response to methylphenidate. Am J Psychiatry 135:1487-1491, 1978.
45. Malone RP, Delaney MA Luebbert JF, Carter J, Campbell M: A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 57:649-654, 2000.
46. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
47. Pelham WE Jr, Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, Moorer S: Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 80:491-501, 1987.
48. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107:E105, 2001.
49. Prinz RJ, Connor PA, Wilson CC. Hyperactive and aggressive behaviors in childhood: Interviewed dimensions. J Abnom Child Psychol 9:191-202, 1981.
50. Pulkkinen L: Offensive and defensive aggression in humans: A longitudinal perspective. Aggressive Behav 13:197-212, 1987.
51. Reeves JC, Werry JS, Elkind GS, Zametkin A: Attention deficit, conduct, oppositional, and anxiety disorders in children: II Clinical characteristics. J Am Acad Child Adolesc Psychiatry 26:144-155, 1987.
52. Reiss AJ, Farrington DP: Advancing knowledge about co-offending: Results from a prospective longitudinal survey of London males. J Crimes Law Criminol 82:360-395, 1991.
53. Rey JM, Bashir MR, Schwarz MR, Richards IN, Plapp JM, Stewart GW: Oppositional disorder: Fact or fiction? J Am Acad Child Adolesc Psychiatry 27:157-162, 1988.
54. Riggs PD, Mikulich SK, Coffman LM, Croley TJ: Fluoxetine in drug dependent delinquence with major depression: An open trial. J Child Adolesc Psychopharmacol 7:87-95, 1997.
55. Rifkin A, Karajgi B, Dicker R, Perl E, Boppana V, Hasan N, Pollack S: Lithium treatment of conduct disorder in adolescents. Am J Psychiatry 154:554-555, 1997.
56. Schachar R, Rutter M, Smith A: The characteristics of situationally and pervasively hyperactive children: Implications for syndrome definition. J Child Psychol Psychiatry 22:375-392, 1981.
57. Schachar R, Wachsmuth R: Oppositional disorder in children: A validation study comparing conduct disorder, oppositional disorder and normal control children. J Child Psychol Psychiatry 31:1089-1102, 1990.
58. Schulz KP, Halperin JM, Newcorn JH, Sharma V, Gabriel S: Plasma cortisol and aggression in boys with ADHD. J Am Acad Child Adolesc Psychiatry 36:605-609, 1997.
59. Sinzig JK, Döpfner M, Plück J, Banaschewski T, Stephani T, Lehmkuhl G, Rothenberger A, Arbeitsgruppe Methylphenidat: Does a morning dose of methylphenidate retard reduce hyperkinetic symptoms in the afternoon? Zeitschrift für Kinder- und Jugendpsychiatrie 32:225-233, 2004.
60. Soltys SM, Kashani JH, Dandoy AC, Vaidya AF, Reid JC: Comorbidity for disruptive behavior in psychiatrically hospitalized children. Child Psychiatry Hum Dev 23:87-98, 1992.
61. Spencer T, Biederman J, Wilens T: Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolescent Psychiatry Clin N Am 9:77-97, 2000.
62. 3H]-imipramine binding sites of platelets of conduct-disordered children. Neuropsychopharmacology 1:55-62, 1987.
63. Szatmari P, Boyle M, Offord DR: ADHD and conduct disorder: Degree of diagnostic overlap and differences among correlates. J Am Acad Child Adolesc Psychiatry 28:865-872, 1989.
64. Taylor E, Chadwick O, Heptinstall E, Danckaerts, M: Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 35:1213-1226, 1996.
65. Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcorn JH, Swanson JM, Cantwell DP: Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 40:188-196, 2001.
66. Weizman A, Bernhout E, Weitz R, Tyano S, Rehavi M: Imipramine binding to platelets of children with attention deficit with hyperactivity. Biol Psychiatry 23:491-498, 1988.
67. Weller E, Rowan Y, Elia J, Weller R: Aggressive behavior in patients with attention-deficit hyperactivity disorder, conduct disorder, and pervasive developmental disorders. J Clin Psychiatry 60 (Suppl. 5):5-11, 1999.
68. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J: Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319-324, 1996.
69. World Health Organization: Multiaxial Classification of Child and Adolescent Psychiatric Disorders. Cambridge, Cambridge University Press, 1996.